| Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5 | | homo-2-mer | 1611-1801 | 100.0 | 2×7AG; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor MCD72 | | homo-2-mer | 1613-1801 | 100.0 | 2×EGW; |
|
| Crystal structure of human poly(ADP-ribose) polymerase 14, catalytic domain in complex with an inhi… | | homo-2-mer | 1613-1801 | 100.0 | 2×XL2; |
|
| Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphate | | monomer | 791-1191 | 100.0 | 2×ADP; |
|
| Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphoribose | | monomer | 791-1191 | 100.0 | 1×AR6; |
|
| Human parp14 (artd8) - macro domain 2 in complex with adenosine-5-diphosphoribose | | monomer | 999-1191 | 100 | 1×AR6; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H10 | | monomer | 1612-1801 | 100.0 | 1×7B8; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK6 | | monomer | 1612-1801 | 100 | 1×EE5; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitor | | monomer | 1612-1801 | 100.0 | 1×94Z; |
|
| PARP14 Macrodomain 2 with inhibitor | | monomer | 1002-1190 | 97.88 | 1×9HH; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with compound 3 | | monomer | 1613-1801 | 100.0 | 1×TZ7; 6×EDO; 1×PEG; 2×GOL; 3×SO4; |
|
| PARP14 catalytic domain in complex with OUL40 | | monomer | 1613-1801 | 100.0 | 1×I1Q; 1×CL; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK1 | | monomer | 1613-1801 | 100 | 1×EBB; |
|
| Human poly(ADP-ribose) polymerase 14 (PARP14/ARTD8) - catalytic domain in complex with 6(5H)-phenan… | | monomer | 1613-1801 | 100.0 | 1×LDR; 2×GOL; |
|
| crystal structure of PARP14 bound to N-{4-[4-(diphenylmethoxy)piperidin-1-yl]butyl}[1,2,4]triazolo[… | | monomer | 1613-1801 | 100.0 | 1×91V; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with RBN012759 | | monomer | 1613-1801 | 100 | 1×XBA; 1×EDO; |
|
| Crystal structure of human poly(adp-ribose) polymerase 14, catalytic fragment in complex with an in… | | monomer | 1613-1801 | 100.0 | 1×3AB; |
|
| Human Artd8 (Parp14, Bal2) - catalytic domain in complex with A16(E) | | monomer | 1613-1801 | 100.0 | 1×0RZ; |
|
| Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a pyrimidine… | | monomer | 1614-1801 | 100 | 1×FDR; 1×GOL; |
|
| Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7,8-tetrah… | | monomer | 1614-1801 | 100.0 | 1×91J; |
|
| Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z) | | monomer | 1615-1801 | 100 | 1×0RY; 1×NO3; |
|
| HUman PARP14 (ARTD8)-Macro domain 1 in complex with adenosine-5-diphosphoribose | | monomer | 792-978 | 100.0 | 1×APR; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with RBN012042 | | monomer | 1615-1801 | 100 | 1×XRM; 2×CL; 1×EDO; |
|
| Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a quinazolin… | | monomer | 1615-1801 | 100.0 | 1×QDR; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with compound 2 | | monomer | 1616-1801 | 100 | 1×FDR; 6×EDO; |
|
| Human PARP14 (ARTD8), catalytic fragment in complex with RBN011980 | | monomer | 1616-1801 | 100 | 1×YFG; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GV4; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×9KS; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GTJ; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GVV; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GUY; |
|
| PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GQY; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GUG; |
|
| PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×AWP; |
|
| PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GW1; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GUV; |
|
| PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GVY; |
|
| PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GV7; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GRY; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GRV; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GWA; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 2×DMS; 1×GT7; |
|
| HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3 | | monomer | 1208-1388 | 100 | 1×BR; |
|
| PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GT4; |
|
| PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with… | | monomer | 1208-1388 | 100 | 2×CL; 1×DMS; 1×GV1; |
|
| HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3 IN COMPLEX WITH ADENOSINE- 5-DIPHOSPHORIBOSE | | monomer | 1208-1388 | 100 | 1×AR6; |
|
| The Crystal Structure of human PARP14 from Biortus. | | monomer | 1208-1387 | 100 | 2×GOL; 2×CL; |
|